UNAIDS - July 25, 2007

"The science presented here in Sydney is not only about new advances in treatment and prevention -- as important as those are -- but also about how to support developing countries in strengthening health delivery systems to make those advances a reality for people in need and at risk," said IAS President Dr. Pedro Cahn, International Conference Co-Chair and Director of Fundacion Huesped in Argentina.

HIV clinicians and community leaders heard reports from some of the world's leading researchers involved in basic, clinical and prevention science. Presentations included the roll out of antiretroviral treatment in the developing world and the need for research to inform treatment scale-up, HIV/TB co-infection, and ethical and practical issues related to HIV prevention research.

Emphasising the need to scale-up TB/HIV programmes Michel Sidibe, UNAIDS Deputy Executive Director of Programmes, UNAIDS said, "Urgent investment in TB research and programmes is needed if we are to avoid TB, and especially drug resistant TB, undoing all the advances we have gained through better AIDS treatment and care. All of our drugs, diagnostics and vaccines date from the last century or even the century before that."

The scientists, clinicians, public health experts and community leaders also heard about research on novel prevention and treatment strategies, the cutting-edge use of gene therapy to treat HIV disease, female-initiated prevention technologies, provider-initiated HIV testing and the prevention of mother-to-child transmission.

"With fewer than one-third of people living with HIV in low- and middle-income countries having access to life-saving medications, and still fewer with access to proven prevention services, such as condoms and sterile syringes, the goal of universal access by 2010 must remain a priority," said IAS President Dr. Pedro Cahn, International Conference Co-Chair and Director of Fundacion Huesped in Argentina. "Science has given us the tools to prevent and treat HIV effectively. The fact that we have not yet translated this science into practice is a shameful failure."

The conference was opened with a declaration from the organizers urging that 10% of all resources dedicated to HIV programming be used for research. By the close, more than 1,550 scientists, clinicians, policy makers and community leaders from around the world had signed the Sydney Declaration.

The International AIDS Society announced the selection of Cape Town, South Africa, as host of the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention in July 2009. The event will be organized by the IAS, in partnership with South African-based non-governmental organisation Dira Sengwe, the organizer of the South African AIDS Conferences.

070725
UN070714

Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .